To hear about similar clinical trials, please enter your email below
Trial Title:
HFNO Reduces Hypoxia During Sedated Gastroscopy or Colonoscopy in High Risk Patients
NCT ID:
NCT05510388
Condition:
Gastric Cancer
Intestinal Cancer
Intestine Adenoma
Gastritis
Conditions: Official terms:
Adenoma
Intestinal Neoplasms
Gastritis
Hypoxia
Conditions: Keywords:
Gastroscopy
High-flow nasal oxygenation
Hypoxia
High-risk
Colonoscopy
Study type:
Interventional
Study phase:
N/A
Overall status:
Unknown status
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Prevention
Masking:
Single (Participant)
Intervention:
Intervention type:
Device
Intervention name:
High-flow nasal cannula oxygenation
Description:
The patients receive oxygen flow of 6L/min for preoxygenation with an high-flow canular
oxygenation device before losing of conscious. Then, the oxygen flow is adjusted to
60L/min with the oxygen concentration of 100% and the temperature of 37℃ until the end of
procedure.
Arm group label:
High-flow nasal cannula oxygenation group
Intervention type:
Device
Intervention name:
Regular nasal cannula oxygenation
Description:
The patients receive an oxygen flow of 6L/min for preoxygenation with a disposal regular
nasal cannula until the end of procedure.
Arm group label:
Regular nasal cannula oxygenation group
Summary:
The objective of this study is to observe the preventive effects of high flow nasal
oxygenation on the incidence of hypoxia during gastroscopy or colonoscopy sedated with
propofol in high-risk patients.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
1. Age ranging from 18 to 80, both sexes
2. Patients receiving selective gastroscopy or colonoscopy or gastroscopy and
colonoscopy procedure
3. ASA Ⅲ~Ⅳ
4. 18 kg/m2
Gender:
All
Minimum age:
18 Years
Maximum age:
80 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
The Second Hospital Affiliated to Chongqing Medical University
Address:
City:
Chongqing
Zip:
404100
Country:
China
Contact:
Last name:
He Huang
Facility:
Name:
Henan Provincial people's hospital
Address:
City:
Zhengzhou
Zip:
450000
Country:
China
Contact:
Last name:
Jiaqiang Zhang
Start date:
September 1, 2022
Completion date:
June 30, 2023
Lead sponsor:
Agency:
RenJi Hospital
Agency class:
Other
Source:
RenJi Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05510388